| Product Code: ETC7663301 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Synucleinopathies Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Synucleinopathies Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Synucleinopathies Market - Industry Life Cycle |
3.4 Israel Synucleinopathies Market - Porter's Five Forces |
3.5 Israel Synucleinopathies Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Synucleinopathies Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Synucleinopathies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of synucleinopathies in Israel |
4.2.2 Advancements in research and development for treatment options |
4.2.3 Growing awareness and focus on early diagnosis and management of synucleinopathies |
4.3 Market Restraints |
4.3.1 High cost of treatment and healthcare services |
4.3.2 Limited access to specialized healthcare facilities for synucleinopathies |
4.3.3 Regulatory challenges in the approval process for new treatments |
5 Israel Synucleinopathies Market Trends |
6 Israel Synucleinopathies Market, By Types |
6.1 Israel Synucleinopathies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Synucleinopathies Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Synucleinopathies Market Revenues & Volume, By AV-1950R, 2021- 2031F |
6.1.4 Israel Synucleinopathies Market Revenues & Volume, By AV-1947D, 2021- 2031F |
6.1.5 Israel Synucleinopathies Market Revenues & Volume, By BAN-0805, 2021- 2031F |
6.1.6 Israel Synucleinopathies Market Revenues & Volume, By BIIB-054, 2021- 2031F |
6.1.7 Israel Synucleinopathies Market Revenues & Volume, By DPC-003, 2021- 2031F |
6.1.8 Israel Synucleinopathies Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Synucleinopathies Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Synucleinopathies Market Revenues & Volume, By Multiple System Atrophy, 2021- 2031F |
6.2.3 Israel Synucleinopathies Market Revenues & Volume, By Neurodegenerateive Disease, 2021- 2031F |
6.2.4 Israel Synucleinopathies Market Revenues & Volume, By Lewy Body Dementia, 2021- 2031F |
6.2.5 Israel Synucleinopathies Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Synucleinopathies Market Import-Export Trade Statistics |
7.1 Israel Synucleinopathies Market Export to Major Countries |
7.2 Israel Synucleinopathies Market Imports from Major Countries |
8 Israel Synucleinopathies Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focused on synucleinopathies in Israel |
8.2 Percentage of patients diagnosed with synucleinopathies receiving timely treatment |
8.3 Adoption rate of innovative diagnostic technologies for synucleinopathies |
9 Israel Synucleinopathies Market - Opportunity Assessment |
9.1 Israel Synucleinopathies Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Synucleinopathies Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Synucleinopathies Market - Competitive Landscape |
10.1 Israel Synucleinopathies Market Revenue Share, By Companies, 2024 |
10.2 Israel Synucleinopathies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here